» Articles » PMID: 34498804

Association of Morning Blood Pressure Surge with Chronic Kidney Disease Progression in Patients with Chronic Kidney Disease and Hypertension

Overview
Date 2021 Sep 9
PMID 34498804
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Blood pressure (BP) usually rise from being asleep to awake, which is named the morning blood pressure surge (MBPS). Researches have reported that elevated MBPS was related with CV events, incident CKD in hypertensive patients. However, there have been no studies that have investigated the association between MBPS and renal or heart outcomes in patients with CKD and hypertension, in these patients, the MBPS is much lower because of high prevalence of night hypertension and reduced BP dipping. In this prospective two-center observational study, we enrolled patients with CKD and hypertension and the 24 h ambulatory blood pressure monitoring (ABPM) was conducted in all patients. Time to total mortality, CKD progression and CV events was recorded; Finally, a total of 304 patients were enrolled and 94 (30.9%) of them had elevated MBPS. After a follow-up for median 30 months, 23 (7.6%), 34 (11.2%), and 95 (31.3%) patients occurred death, CKD progression and new-onset CV events, respectively. The Cox regression analysis suggested the elevated MBPS was a strong predictor of CKD progression (HR 2.35, 95%CI 1.2 -4.63, p = .013), independent of morning BP, while no associations were found between elevated MBPS and CV events (HR 1.02, 95%CI 0.66 -1.57), as well as death (HR 1.08, 95%CI 0.46 -2.55). In conclusion, we provided the first evidence that elevated MBPS was an important risk factor of CKD progression in patients with CKD and hypertension. Appropriate evaluation and management of MBPS may be helpful to postpone CKD progression.

Citing Articles

Correlation of ACE gene polymorphisms and platelet parameters with morning peak blood pressure in hypertensive patients.

Mao Y, Yu L Am J Transl Res. 2025; 16(12):7656-7666.

PMID: 39822542 PMC: 11733366. DOI: 10.62347/RNWD3336.


Plasma Biomarkers for Hypertension-Mediated Organ Damage Detection: A Narrative Review.

Liu X, Yang M, Lip G, McDowell G Biomedicines. 2024; 12(5).

PMID: 38791032 PMC: 11118189. DOI: 10.3390/biomedicines12051071.


Prognostic Effect of Masked Morning Hypertension in Chinese Inpatients With Non-dialysis Chronic Kidney Disease: A Multicenter Retrospective Study.

Lin L, Jiang X, Liu L, Wu J, Yu T, Wei Y Am J Hypertens. 2024; 37(8):621-630.

PMID: 38625716 PMC: 11247133. DOI: 10.1093/ajh/hpae044.


Short-term blood pressure variability as a potential therapeutic target for kidney disease.

Ko Y, Jhee J Clin Hypertens. 2023; 29(1):23.

PMID: 37580839 PMC: 10426225. DOI: 10.1186/s40885-023-00248-3.


Nocturnal heart rate rising is a risk factor for poor renal outcomes in patients with chronic kidney disease and hypertension.

Liu X, Zhou H, Li G, Li F, Dong L, Wang S J Clin Hypertens (Greenwich). 2022; 24(3):292-299.

PMID: 35130369 PMC: 8925008. DOI: 10.1111/jch.14428.


References
1.
Bombelli M, Fodri D, Toso E, Macchiarulo M, Cairo M, Facchetti R . Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population. Hypertension. 2014; 64(5):943-50. DOI: 10.1161/HYPERTENSIONAHA.114.03675. View

2.
Bankir L, Bochud M, Maillard M, Bovet P, Gabriel A, Burnier M . Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects. Hypertension. 2008; 51(4):891-8. DOI: 10.1161/HYPERTENSIONAHA.107.105510. View

3.
Li X, Lian R, Zhu Y, Ke J, Li M, Wang C . Masked morning hypertension correlated with target organ damage in non-dialysis patients with chronic kidney disease. J Hypertens. 2020; 38(9):1794-1801. DOI: 10.1097/HJH.0000000000002461. View

4.
Booth 3rd J, Jaeger B, Huang L, Abdalla M, Sims M, Butler M . Morning Blood Pressure Surge and Cardiovascular Disease Events and All-Cause Mortality in Blacks: The Jackson Heart Study. Hypertension. 2020; 75(3):835-843. PMC: 7035156. DOI: 10.1161/HYPERTENSIONAHA.119.14233. View

5.
Ketteler M, Block G, Evenepoel P, Fukagawa M, Herzog C, McCann L . Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update. Ann Intern Med. 2018; 168(6):422-430. DOI: 10.7326/M17-2640. View